AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Trends Analyst Outlook Journalist POV

89 hedge funds and large institutions have $373M invested in Avadel Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

67% less funds holding in top 10

Funds holding in top 10: 6 → 2 (-4)

Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.85M
Puts
$1.22M
Net Calls
Net Calls Change

Top Buyers

1
+$10M
2
+$5.79M
3
+$5.39M
4
Morgan Stanley
Morgan Stanley
New York
+$4.99M
5
FPC
Falcon Point Capital
California
+$4.18M

Top Sellers

1
-$11.9M
2
-$10.9M
3
-$9.91M
4
GTC
Ghost Tree Capital
New York
-$5.71M
5
CPIM
Columbia Partners Investment Management
Virginia
-$3.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.8M
27
$2.69M
28
$2.14M
29
$2.13M
30
$2.09M
31
$1.91M
32
$1.9M
33
$1.51M
34
$1.28M
35
$1.24M
36
$1.22M
37
$1.13M
38
$1M
39
$896K
40
$831K
41
$818K
42
$729K
43
$693K
44
$629K
45
$595K
46
$577K
47
$502K
48
$498K
49
$442K
50
$424K
1
2
3 4 5